Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed: 3,385
Companies: 1,062
Pipeline programs: 18,156

Quick answer

NovaPharmaNews tracks 3,385 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 3,385 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources

Quick answer

anagrelide hydrochloride

anamorelin

anifrolimab-fnia

antazoline phosphate

atezolizumab

atezolizumab and hyaluronidase-tqjs

autologous glioma tumor cell lysates (inactivated)

axatilimab-csfr

azlocillin sodium

bacampicillin hydrochloride

basiliximab

bedaquiline

bedaquiline fumarate

belimumab

belinostat

benralizumab

bexagliflozin

bismuth subsalicylate

bivalirudin

blinatumomab

botulinum toxin type a

botulinum toxin type b

bretylium tosylate

brilliant blue g

Frequently asked questions